PRP vs Minoxidil for Pattern Hair Loss: 2025 Meta-Analysis Research Summary
This is a plain-language summary of the original published research. We do not add conclusions or opinions of our own. This is not medical advice — consult a certified healthcare practitioner before making any decision.
Original research published in PubMed 2025, 2025
PRP vs Minoxidil for Pattern Hair Loss: 2025 Meta-Analysis Research Summary
Study conclusion
This meta-analysis of 9 randomised controlled trials involving 451 patients found no significant difference in hair density improvement between PRP (platelet-rich plasma injections) and topical minoxidil for pattern hair loss. Both treatments produced similar hair density outcomes when compared directly.
Strength of evidence
Who it applies to
Who was studied
Adults with pattern hair loss. 451 participants across 9 RCTs. PRP compared directly against topical minoxidil.
Who was NOT studied
People using PRP combined with minoxidil. Long-term effects beyond trial periods.
What to look for when shopping
PRP is a clinic-based procedure. Minoxidil is available OTC (2%, 5%) and is FDA-approved for pattern hair loss. PRP is not FDA-approved.
What research cannot help you decide
Whether PRP is a reasonable alternative to minoxidil for your situation given the cost, inconvenience, and lack of FDA approval. This is a clinical decision requiring a doctor.
Key findings
- No significant difference in hair density improvement between PRP and topical minoxidil across 9 RCTs
- Both treatments produced similar results when compared head to head
- PRP is not FDA-approved for hair loss; topical minoxidil is FDA-approved
- PRP requires clinic visits and injections; minoxidil is a daily home treatment
- High variability in PRP protocols across trials may affect how much the pooled result applies to any specific clinic
What this study does not show
- 1.Whether combining PRP with minoxidil produces better results than either alone.
- 2.Which PRP preparation protocol produces the best results.
- 3.Long-term comparative outcomes beyond trial periods.
Limitations
- 1.PRP preparation protocols varied substantially across trials.
- 2.PRP is not FDA-approved for hair loss; topical minoxidil is.
- 3.9 trials with 451 participants is a moderate evidence base for a definitive comparison.
- 4.Full journal details pending PMID confirmation.
Used in these articles
Links added as fact-checks and articles citing this study are published.